A 2023 pilot study shows promising safety for IV BPC-157 in treating musculoskeletal injuries, but regulatory hurdles and off-label use raise concerns. Recent research highlights BPC-157’s poten...
Recent studies show herbal cubosomes significantly improve arthritis treatment by enhancing the bioavailability of compounds like curcumin and boswellic acid, reducing inflammation markers by up to 40...
Recent studies show herbal cubosomes offer targeted, sustained relief for arthritis with fewer side effects than conventional treatments, backed by clinical trials and FDA approvals. Herbal cubosomes ...
